Immunotherapy for dMMR glioma

Immunotherapy for dMMR glioma - Immunotherapy for dMMR glioma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON57655

Enrollment

Registered

2024-08-30

Start date

2024-10-01

Completion date

Unknown

Last updated

2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain tumor Brain tumor

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: dMMR brain tumor

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
(epi)genetic or immunological predictors of respons on immunotherapy	—

Countries

Netherlands

Contacts

Public ContactM. Geurts

Erasmus MC, Universitair Medisch Centrum Rotterdam

neuro-oncologie@erasmusmc.nl010-7041415

Outcome results